Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JNJ-17166864 in seasonal allergic rhinitis
NCT00604123Phase 2Completed
- Sponsor
- Johnson & Johnson
- Start
- Jan 2008
- Primary completion
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of JNJ-17166864 in seasonal allergic rhinitis (SAR), sponsored by Johnson & Johnson. Started Jan 2008; status: completed.
02
Drugs
JNJ-17166864
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT00604123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00604123.